A growing amount of evidence suggests that obstructive sleep apnea syndrome (OSAS) is the most common cause of secondary hypertension; however, an estimated 70-90 % of cases go undiagnosed.
Meditech apneABP combines ambulatory blood pressure (ABP), pulse oximetry (SpO2) and actigraphy monitoring in one easy-to-use device, so it can be considered almost a miniature ambulatory sleep lab, the perfect state-of-the-art tool for screening patients with suspected OSAS.
What is OSAS?
Obstructive sleep apnea syndrome (OSAS) is found by a number of studies to be present in as much as 12-14 % of the adult population. An obstructive sleep apneic episode is usually defined as lack of oronasal airflow for a period of at least 10 seconds during sleep, caused by pharyngeal obstruction, with blood oxygen desaturation, preceded by growing breathing efforts and followed by signs of full or partial awakening. OSAS is defined as at least 5 such episodes per hour of sleep.
Relationship between OSAS & Hypertension
Up to 70-80% of OSAS patients are hypertensive; approximately 40% of hypertensive patients have obstructive sleep apnea. OSAS is shown to be present in as much as 60% of therapy-resistant hypertension cases.
A growing amount of evidence suggests that OSAS is the most common type of secondary hypertension; however, an estimated 70-90 percent of cases go undiagnosed.
OSAS independently elevates the risk of cardiovascular mortality by a factor of 10 to 23 times to normal. It causes a 7 to 10 times growth in cerebrovascular mortality and a 15 to 20 times growth in the risk of sleep-related traffic and work accidents. It is a major contributing factor in a large part of early mental deficit symptoms. Untreated severe OSAS lowers cumulative survival of patients by 30% in 5 years from diagnosis; and by 40% in 7 years.
Sleep Labs May Not Be Available
Diagnostic protocols require patients with suspected OSAS to be referred to fully equipped sleep labs which may not be readily available either in a convenient time range or in a nearby institute. Therefore, an effective and easily available screening method is really important.
Meditech apneABP - the Innovative 3in1 Device
The new apneABP monitor from Meditech combines ambulatory blood pressure, pulse oximeter and actigraphy monitoring in one device for the diagnosis of hypertension and sleep-related breathing disorders. Avoid costly and time-consuming examinations in sleep labs with apneABP, the perfect screening tool for patients with suspected OSAS.
Introductory prices are available!
For more information, please contact Meditech!